Surgery for Non-Small Cell Lung Cancer in the Personalized Therapy Era

Marco Chiappetta; Carolina Sassorossi; Giacomo Cusumano

doi:10.3390/curroncol30080563

Surgery for Non-Small Cell Lung Cancer in the Personalized Therapy Era

Curr Oncol. 2023 Aug 21;30(8):7773-7776. doi: 10.3390/curroncol30080563.

Authors

Marco Chiappetta^{1

2}, Carolina Sassorossi^{1

2}, Giacomo Cusumano³

Affiliations

¹ Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
² Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
³ Thoracic Surgery Unit, Policlinico-San Marco Hospital, University of Catania, 95124 Catania, Italy.

Abstract

Lung cancer remains one of the tumours with the highest incidence and the poorestprognosis, with an estimated incidence of more than 220,000 cases with 135,000 cancerrelateddeaths annually in the United States [1,2].[...].

Publication types

Editorial

MeSH terms

Carcinoma, Non-Small-Cell Lung* / surgery
Humans
Lung Neoplasms* / surgery